ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Avience Biomedicals Ltd reported revenue from operations of ₹31.1 Cr (+16.0% YoY) and net profit of ₹5.5 Cr (+22.2% YoY) for H1 FY27.
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.
Avience Biomedicals Limited has appointed M.A.M and Associates, GR Gupta & Associates, and V C A N & Co LLP as its statutory, secretarial, and internal auditors.
Avience Biomedicals Limited held its 7th AGM on September 30, 2026. Shareholders approved borrowing limits up to ₹100 Crore and the appointment of new statutory auditors.
Avience Biomedicals Limited has scheduled its 7th Annual General Meeting for September 30, 2026. The company also announced book closure dates for the AGM.